Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - Hepatitis B virus - Inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?

European Journal of Pediatrics

Volumn 158, Issue 5, 1999, Pages 398-402

  Usonis, V ^b   Bakasenas, V ^a  

^a Centre for Communicable Diseases Prevention and Control   (Lithuania)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Conjugate polysaccharide vaccine; Haemophilus influenzae type b; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE;

ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIPHTHERIA; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFANT; INJECTION PAIN; MAJOR CLINICAL STUDY; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; TETANUS; VACCINATION; VOMITING;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BACTERIAL PROTEINS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; INFANT; POLIOVIRUS VACCINE, INACTIVATED; POLYSACCHARIDES, BACTERIAL; TETANUS TOXOID; VACCINATION; VACCINES, COMBINED; VACCINES, CONJUGATE;

EID: 0032895671     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051100     Document Type: Article

References (12)

1. 1. Ault A (1997) Combination DPT/Hib vaccine fails FDA test. Lancet 349:1752
2. 2. Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI (1993) Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska native infants. Pediatr Infect Dis J 12:484-492
3. 3. CDC (1997) Recommended childhood immunization schedule -United States, 1997. MMWR 46:35-40
4. 4. Decker MD, Edwards KM, Bradley R, Palmer P (1992) Comparative trial in infants of four conjugate Haemophilus influenzas type b vaccines. J Pediatr 120:184-189
5. 5. Eskola J, Käyhty H (1996) Ten years' experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland. Rev Med Microbiol 7:231-234
6. 6. Eskola J, Ölander R-M, Hovi T, Litmanen L, Peltola S, Käyhty H (1996) Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 348:1688-1692
7. 7. Hoppenbrouwers K, Kanra G, Silier T, et al (1997) Priming effect of the combined DTaP/Act-Hib™ vaccine. 15th Annual Meeting of the European Society of Pediatrics, Paris, 22-23 May 1997 (abstract)
8. 8. Käyhty H, Peltola H, Karanko V, Mäkelä PH (1983) The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 147:1100
9. 9. Pichichero ME, Christy C, Decker MD, et al (1995) Defining the key parameters for comparing reactions among acellular and whole-cell pertussis vaccines. Pediatrics 96:588-592
10. 10. Schmitt H-J (1996) Acellular pertussis vaccines: the final countdown. Eur J Ped 155:74-76
11. 11. Zepp F, Schmitt H-J, Kaufhold A, Schuind A, Knuf M, Habermehl P, Bogaerts H, Slaoui M, Clemens R (1997) Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life; plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr 156:18-24
12. 12. Zsolway K, Chilkatowsky A, Watson B (1997) Comparison of immunogenicity and of a combination vaccine (Tetracel) with separate vaccines of DTaP and HbOC. Pediatric Academic Societies' Annual Meeting, Washington, May 2-6 1997 (abstract)